Cargando…
Metacognitive Therapy of Early Traumatized Patients With Borderline Personality Disorder: A Phase-II Baseline Controlled Trial
Metacognitive therapy (MCT) is proving to be an effective and brief treatment for anxiety disorders and depression, but there are no investigations of its feasibility and effect on primary personality disorders. We conducted a baseline controlled phase II trial of MCT on a group of patients with Bor...
Autores principales: | Nordahl, Hans M., Wells, Adrian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682682/ https://www.ncbi.nlm.nih.gov/pubmed/31417453 http://dx.doi.org/10.3389/fpsyg.2019.01694 |
Ejemplares similares
-
Metacognitive Therapy for Social Anxiety Disorder: An A–B Replication Series Across Social Anxiety Subtypes
por: Nordahl, Henrik, et al.
Publicado: (2018) -
Editorial: Metacognitive Therapy: Science and Practice of a Paradigm
por: Wells, Adrian, et al.
Publicado: (2020) -
Metacognitive Beliefs Uniquely Contribute to Interpersonal Problems: A Test Controlling for Adult Attachment, Big-5 Personality Traits, Anxiety, and Depression
por: Nordahl, Henrik, et al.
Publicado: (2021) -
A Randomized Controlled Trial of Metacognitive Therapy for Depression: Analysis of 1-Year Follow-Up
por: Hjemdal, Odin, et al.
Publicado: (2019) -
Metacognitive Therapy for Depression in Adults: A Waiting List Randomized Controlled Trial with Six Months Follow-Up
por: Hagen, Roger, et al.
Publicado: (2017)